
The Allegretti Lab
@allegrettilab
Clinical and translational research lab focusing on C. difficile infection and inflammatory bowel diseases lead by Dr. Jessica Allegretti @DrJessicaA
ID: 1501190194174865410
https://www.allegrettilab.com/ 08-03-2022 13:36:53
23 Tweet
121 Followers
47 Following

EBGI: Infliximab Therapy Is Associated w/ Reduced Antibody Responses Against SARS-CoV-2 Reviewers: Dr. Rahul Dalal & Dr. Jessica Allegretti 🟣 Read: bit.ly/3JgFuWz Jessica R Allegretti Jennifer Kolb @KumarShria Philip Okafor @spaulliver Joseph Sleiman, MD, FACP Swati G. Patel, MD MS Rahul S. Dalal, MD, MPH


Congrats to our faculty named 2022 Top Doctors by Boston Magazine! #TopDocs 🌟Jessica R Allegretti #BWHIBD 🌟Walter Chan, MD, MPH #BWHMotility 🌟Alison Goldin MD MPH 🌟Nikroo Hashemi MD #BWHLiver 🌟Joshua Korzenik MD #BWHIBD 🌟Muthoka Mutinga MD 🌟John Saltzman MD #BWHEndoscopy 🌟Benjamin Smith MD


Newest member of the The Allegretti Lab. Thank you Christina Ha MD for my stuffed #cdiff


It was a great meet up with friends Edward Loftus Bincy Abraham, MD, MS Christina Ha MD Jessica R Allegretti at #DDW2022 American Gastroenterological Association (AGA) Digestive Disease Week


Jessica R Allegretti of Brigham and Women's GI discusses her trial of an oral #microbiome therapeutic that effectively reduces recurrent #Cdiff Digestive Disease Week #DDW2022 The Allegretti Lab


Congratulations to 3rd-yr #BrighamGIFellow Rahul S. Dalal, MD, MPH on graduating w/ his Master of Public Health degree from Harvard T.H. Chan School of Public Health 👨🎓🎉🎓 We are so proud of you & look forward to your continued success as a clinical investigator! #HarvardChan22 #Harvard22 #MDMPH The Allegretti Lab


The Allegretti Lab Parambir Dulai CS Tse, MD #AdamChiefetz #KostasPapamichael Phillip Gu Annie Feagins, MD Jennifer Seminerio Amy Lee Lightner, MD David T. Rubin, MD Rishika Chugh Jill Gaidos, MD Simon Hong Seymour Katz Jana G Hashash, MD, MSc Francis (Frank) Farraye, MD, MSc #JoelRoshMD

Data re: #tofacitinib for #pouchitis and related disorders are lacking. We The Allegretti Lab Brigham and Women's GI published our single center experience in IBDJournal & CC360 : Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series academic.oup.com/ibdjournal/adv…

Study from #BrighamIBDFellow Rahul S. Dalal, MD, MPH The Allegretti Lab on long-term outcomes after #ustekinumab dose⬆️ for #IBD 🔑>50% in corticosteroid-free remission (CFCR) after 12mo 🔑≥40% in CFCR after 24mo 🔑43% CD & 55% UC pts in endo remission IBDJournal & CC360: doi.org/10.1093/ibd/iz…


Join Us! BWH is accepting applications for 2023-24 Advanced IBD Fellowship. 1-year, comprehensive training program and includes opportunities for coursework at the Harvard School of Public Health. Direct inquiries to PD Matthew Hamilton MD [email protected]. Q's ⬇️

So thrilled our data on the potential role of BAs as novel #biomarkers for #CDI recurrence is out! Thank you ACG for funding this work. And big thanks to Ben Mullish and Imperial College London for getting us to the finish line! bit.ly/3S8Yda2


Congratulations to our Medical Director of Crohn's and Colitis Center & Director of Clinical Research Dr. Jessica Allegretti (Jessica R Allegretti) for her #promotion to Associate Professor at Harvard Medical School Harvard Medical School 🎉 #BWHIBD #BrighamGIFaculty #BrighamGIAlum The Allegretti Lab


Congratulations to our 1️⃣4️⃣ faculty named Top Doctors 2023 by Boston Magazine! #TopDocs⚕️ Thank you to our dedicated #BrighamGIFaculty for their passion & commitment to providing top-notch & cutting-edge care in digestive & liver health to our patients🩺 bostonmagazine.com/find-a-doctor/…


Higher steroid free remission on ups than on uste in a real word cohort per Rahul S. Dalal, MD, MPH Edward Barnes MD MPH Jessica R Allegretti


The Allegretti Lab super star Rahul S. Dalal, MD, MPH presenting data on real world outcomes of comparative effectiveness for #IBD therapies. #DDW2023


Check out our data on utilizing colonic washes to identify c.difficile colonization in #IBD patients undergoing colonoscopy The Allegretti Lab #DDW2023


Thank you Jessica R Allegretti, MD, MPH, FACG, AGAF! Some 🔑 pts: ⭐️Tramadol a/w ⬇️ odds of infection, SBO, and mortality vs traditional opioids in IBD, though there may be residual confounding. ⭐️Rx these cautiously and only when necessary! Treat the IBD. ⭐️ More 🔬 is needed comparing analgesics.

Our Brigham and Women's GI The Allegretti Lab study comparing 1-year effectiveness of tofa vs uste for #UC is out in IBDJournal & CC360: doi-org.ezp-prod1.hul.harvard.edu/10.1093/ibd/iz… 🔑After adjusting for confounders, no difference in steroid-free remission at 12 or 52 wks 🔑Similar drug survival during follow-up
